Loading company…
Neuroceuticals iVNS develops vagus nerve stimulation and other medical devices.
Neuroceuticals iVNS develops medical devices, including a vagus nerve stimulation catheter intended to deliver electrical stimulation to nerves involved in seizures and pain. The company is also developing devices for heart surgery and external neurostimulation. Founded in 2022, it is based in Tokyo, Japan, and was led by CEO Shinya Miike as of 2023. In December 2022, it raised JPY 150 million from RMD Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in